| Page No 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 |
| Phrase | Consultant | Town | Special Interests |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, hepatopancreatobiliary cancer, neuroendocrine tumours |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gastrointestinal oncology, lung cancer and mesothelioma, neuroendocrine tumours, cancer of unknown primary, malignant melanoma, kidney cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, urological cancer, malignant melanoma, skin malignancies |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, mesothelioma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, ovarian cancer, sarcoma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, acute oncology, cancer of unknown primary, upper gastrointestinal cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, urological oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, colorectal and upper gastrointestinal tumours, mesothelioma, lung cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, head and neck cancer, phase 1 drug development |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, renal cancer, melanoma, acute oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, melanoma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gynaecological oncology, ovarian cancer, translational research |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, urological cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, upper gastrointestinal cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, urological cancer - kidney and testis, lung cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, bowel cancer, stomach cancer, oesophageal cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, germ cell tumours, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gastrointestinal cancer, cancers of unknown primary |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, lung cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, prostate cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gynaecological cancer, translational research |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, renal cell cancer, melanoma, pancreatic tumours |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, ovarian cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, development of new anti-cancer drugs |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, renal cancer, lung cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, testicular cancer, melanoma, renal cell cancer, Training Programme Director |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, melanoma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gynaecological oncology, ovarian cancer, lower gastrointestinal cancers |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gynaecological oncology, ovarian cancer, cancer informatics |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, sarcoma |
| medical oncology | *Consultant(s)* | *Towns* | Clinical oncology, medical oncology, breast cancer, urological cancer, sarcoma and palliative care |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, testicular cancer, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Page No 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 |
